CoChat

Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Serum alanine aminotransferase (ALT) is a marker of liver injury. The 2005 American Gastroenterology Association Future Trends Committee report states that serum ALT levels remain constant with age. This study examines the association between serum ALT and age in a community-dwelling cohort in the United States. METHODS: A cross-sectional study of 2,364 (54% female) participants aged 30-93 years from the Rancho Bernardo Study cohort who attended a research clinic visit in 1984-87. Demographic, metabolic co-variates, ALT, bilirubin, gamma glutamyl transferase (GGT), albumin, and adiposity signaling biomarkers (leptin, IL-6, adiponectin, ghrelin) were measured. Participants were divided into four-groups based upon age quartile, and multivariable-adjusted least squares of means (LSM) were examined (p for trend <0.05). RESULTS: ALT decreased with increasing age, with mean ALT levels (IU/L) of 23, 21, 20, and 17 for those between quartile ages 30-62, 63-71, 72-77, and 78-93 years (p<0.0001). Trends of decreasing LSM ALT with age and the decreasing prevalence of categorically defined elevated serum ALT with age remained robust after adjusting for sex, alcohol use, metabolic syndrome components, and biomarkers of adiposity (p-value <0.0001), and was not materially changed after adjusting for bilirubin, GGT, and albumin. CONCLUSIONS: ALT levels decrease with age in both men and women independent of metabolic syndrome components, adiposity signaling biomarkers, and other commonly used liver function tests. Further studies are needed to understand the mechanisms responsible for a decline in ALT with age, and to establish the optimal cut-point of normal ALT in the elderly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0014254

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effect of Age on ALT Values in Men (Mean and 95% Confidence Interval). In men, mean ALT (bars) and 95th percentile cutoff ranges (extension lines) both decrease with rising age.
Figure 1 Effect of Age on ALT Values in Men (Mean and 95% Confidence Interval). In men, mean ALT (bars) and 95th percentile cutoff ranges (extension lines) both decrease with rising age.CC BY · PubMed Central
Figure 2 Effect of Age on ALT Values in Women (Mean and 95% Confidence Interval). In women, mean ALT (bars) and 95th percentile cutoff ranges (extension lines) both decrease with rising age.
Figure 2 Effect of Age on ALT Values in Women (Mean and 95% Confidence Interval). In women, mean ALT (bars) and 95th percentile cutoff ranges (extension lines) both decrease with rising age.CC BY · PubMed Central
Figure 3 Prevalence of Elevated ALT by Age. The trend of decreasing prevalence of elevated ALT with rising age persists in unadjusted analysis, after adjustment for sex, BMI, systolic blood pressure, alcohol use, waist-hip ratio, diabetes, fasting glucose, total-HDL ratio, triglycerides, adiposity biomarkers (leptin, adiponectin, ghrelin, IL-6), and after adjustments for the above plus bilirubin, GGT, and albumin.
Figure 3 Prevalence of Elevated ALT by Age. The trend of decreasing prevalence of elevated ALT with rising age persists in unadjusted analysis, after adjustment for sex, BMI, systolic blood pressure, alcohol use, waist-hip ratio, diabetes, fasting glucose, total-HDL ratio, triglycerides, adiposity biomarkers (leptin, adiponectin, ghrelin, IL-6), and after adjustments for the above plus bilirubin, GGT, and albumin.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 103

Metadata

Authors
Dong, M. H., Bettencourt, R., Barrett-Connor, E., & Loomba, R.
Affiliations
University of California San Diego (US)
Corresponding author
Loomba, Rohit
Venue
PLoS ONE
Published
2010-12-08
Volume
5
Issue
12
Pages
e14254
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2033937045
Cited by
103
References
52
Citations by year
2026: 3 · 2025: 12 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 7 · 2018: 1 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 11 · 2013: 4 · 2012: 5
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • John A. Hartford Foundation (DK080506)
  • Hartford Foundation for Public Giving
  • American Gastroenterological Association (DK080506)
  • National Institutes of Health (DK080506)
  • University of California, San Diego (DK080506)
  • National Institute on Aging (R37AG007181, R01AG28507, R01AG028507)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R24DK080506, DK 080506, R01DK031801, R01 DK 31801)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
alanine aminotransferase, aging, liver function tests, metabolic syndrome, adiposity biomarkers, leptin, interleukin-6, adiponectin, ghrelin, gamma-glutamyl transferase, bilirubin, albumin, older adults
MeSH terms
Adipose Tissue, Adult, Age Factors, Aged, Aged, 80 and over, Aging, Alanine Transaminase, Albumins, Bilirubin, California, Female, gamma-Glutamyltransferase, Humans, Liver Diseases, Male, Middle Aged, Cohort Studies, Interleukin-6, Leptin, Adiponectin, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study. https://app.cochat.ai/papers/10.1371/journal.pone.0014254
The paper
Dong, M. H., Bettencourt, R., Barrett-Connor, E., & Loomba, R. (2010). Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study. PLoS ONE. https://doi.org/10.1371/journal.pone.0014254

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.